Literature DB >> 21505954

Quality assessment of umbilical cord blood units at the time of transplantation.

Yoshinori Kudo1, Masayoshi Minegishi2, Osamu Seki1, Hiroyuki Takahashi1, Akira Suzuki1, Ayuko Narita1, Yuko Sato1, Machiko Abe1, Natsuko Ishioka1, Hideo Harigae3, Shigeru Tsuchiya4.   

Abstract

Total nucleated cell (TNC) count, CD34(+) cell count, colony-forming unit-granulocyte-macrophage (CFU-GM) content, and cell viability impact the outcome of umbilical cord blood (UCB) transplantation. Assessments of unit quality have usually been provided by cord blood banks (CBBs), but it is unclear whether pre-freezing tests or pre-transplant release tests performed by CBBs are reproducible. The aim of this study was to compare the UCB characteristics analyzed at the site of infusion of the UCB with those provided by CBBs. Samples were taken from 54 UCB units for assessment of post-thaw characteristics. TNC counts and CD34(+) cell contents measured at our hospital before infusion showed good correlations with values assessed in pre-freezing tests (r = 0.900 and 0.943, respectively) and pre-transplant release tests (r = 0.829 and 0.930, respectively). Our data reveal that the TNC counts and CD34(+) cell contents determined by pre-freezing and pre-transplant release tests, which are the most important UCB unit selection criteria, accurately reflected the quality of infused UCB units. However, CFU-GM content was poorly correlated (r = 0.560 and 0.606). Correlation of post-thaw cell viabilities measured before infusion and during the pre-transplant release tests was also poor (r = 0.308). We suggest that the TNC count and CD34(+) cell content estimated before cryopreservation and in pre-transplant release tests provided by CBBs are reproducible and can assist the transplant physicians in selection of appropriate UCB units.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505954     DOI: 10.1007/s12185-011-0830-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank.

Authors:  Tokiko Nagamura-Inoue; Mika Shioya; Michiko Sugo; Yan Cui; Atsuko Takahashi; Satomi Tomita; Yizhou Zheng; Kei Takada; Hideki Kodo; Shigetaka Asano; Tsuneo A Takahashi
Journal:  Transfusion       Date:  2003-09       Impact factor: 3.157

2.  Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved by a simple controlled-rate freezing method.

Authors:  Yoshinori Kudo; Masayoshi Minegishi; Tsuneo Itoh; Junko Miura; Naoko Saito; Hiroyuki Takahashi; Akira Suzuki; Ayuko Narita; Yuko Sato; Jun-ichi Kameoka; Masue Imaizumi; Makoto Sato; Yasuko Murakawa; Shigeru Tsuchiya
Journal:  Tohoku J Exp Med       Date:  2005-01       Impact factor: 1.848

3.  Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.

Authors:  M Keeney; I Chin-Yee; K Weir; J Popma; R Nayar; D R Sutherland
Journal:  Cytometry       Date:  1998-04-15

4.  Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective.

Authors:  Alessandra Picardi; William Arcese
Journal:  Transfus Apher Sci       Date:  2010-04-09       Impact factor: 1.764

5.  Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks.

Authors:  Eric Wagner; Michel Duval; Jean-Hugues Dalle; Hugo Morin; Sonia Bizier; Josette Champagne; Martin A Champagne
Journal:  Transfusion       Date:  2006-07       Impact factor: 3.157

6.  Optimal cryopreservation of human umbilical cord blood.

Authors:  C Donaldson; W J Armitage; P A Denning-Kendall; A J Nicol; B A Bradley; J M Hows
Journal:  Bone Marrow Transplant       Date:  1996-10       Impact factor: 5.483

7.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

8.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

9.  Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells.

Authors:  Cladd E Stevens; Jessica Gladstone; Patricia E Taylor; Andromachi Scaradavou; Anna Rita Migliaccio; Jan Visser; N Ludy Dobrila; Carmelita Carrier; Michael Cabbad; Peter Wernet; Joanne Kurtzberg; Pablo Rubinstein
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.

Authors:  A P Iori; R Cerretti; L De Felice; M Screnci; A Mengarelli; A Romano; M Caniglia; L Cerilli; G Gentile; M L Moleti; F Giona; F Agostini; I Pasqua; M P Perrone; M R Pinto; L Grapulin; A M Testi; P Martino; G De Rossi; F Mandelli; W Arcese
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

View more
  7 in total

1.  Cord blood unit factors influencing transplant outcomes from the Asian multiethnic Singapore Cord Blood Bank.

Authors:  S-Y Ong; C Phipps; P Chu; A Prasath; A Y L Ho; S J Sobak; W Hwang
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

2.  Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?

Authors:  L Faivre; H Boucher; R Zerbib; T Domet; A Desproges; C Couzin; V Vanneaux; J Larghero; A Cras
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

3.  Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation.

Authors:  N Kurita; F Frassoni; S Chiba; M Podestà
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

4.  Umbilical cord blood transplant for malignancies: a hope or hype.

Authors:  Ankur Bahl; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2013-05-10       Impact factor: 1.967

5.  Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.

Authors:  Eiman Hussein; Todd DeFor; John E Wagner; Darin Sumstad; Claudio G Brunstein; David H McKenna
Journal:  Transfusion       Date:  2019-11-22       Impact factor: 3.157

6.  Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells.

Authors:  Darshana Kadekar; Sonal Rangole; Vaijayanti Kale; Lalita Limaye
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

7.  Modelling improvements in cell yield of banked umbilical cord blood and the impact on availability of donor units for transplantation into adults.

Authors:  Natasha Kekre; Jennifer Philippe; Ranjeeta Mallick; Susan Smith; David Allan
Journal:  Stem Cells Int       Date:  2013-02-20       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.